| Sep 12 2025 |
FDA's AI-Powered Crackdown on Alleged Deceptive Drug Promotions |
Katten |
| Sep 12 2025 |
McDermott+ Check-Up: September 12, 2025 |
McDermott Will & Schulte LLP |
| Sep 12 2025 |
FDA on the Offense! Targeting Pharmaceutical Company Drug Advertising in Wave of Enforcement Actions |
Foley & Lardner LLP |
| Sep 12 2025 |
FDA Launches Crackdown on Deceptive Drug Advertising and Initiates Rulemaking |
Barnes & Thornburg LLP |
| Sep 12 2025 |
AAFCO Annual Meeting Updates |
Keller and Heckman LLP |
| Sep 12 2025 |
FDA Releases Unified Agenda, Intends to Prioritize GRAS, FOP, and Dietary Ingredients |
Keller and Heckman LLP |
| Sep 11 2025 |
Responses to DOD Survey on Alternatives to TSCA High Priority Chemicals Due September 26, 2025 |
Bergeson & Campbell, P.C. |
| Sep 11 2025 |
USDA Extends Comment Period on Reorganization Plan to September 30, 2025 |
Bergeson & Campbell, P.C. |
| Sep 11 2025 |
International Update: Canada and New Zealand |
Blank Rome LLP |
| Sep 11 2025 |
Court Allows Biohaven and Yale’s Trade Secret Claims to Proceed in MODA Technology Dispute |
ArentFox Schiff LLP |
| Sep 10 2025 |
FDA’s Vast Ad/Promo Warning – Enforcement Ramp-Up or PR Nothingburger? |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 10 2025 |
Pots of Gold, Availability of State and Local Incentives for Manufacturing Operations |
Foley & Lardner LLP |
| Sep 10 2025 |
Turning Over a New Leaf: How Cannabis Receiverships Can Cultivate a Stronger Future |
Blank Rome LLP |
| Sep 9 2025 |
Puerto Rico Senate Approves Resolution Backing U.S. Actions Against Maduro |
MZLS Law |
| Sep 9 2025 |
FDA Seeks Public Input on 2025 Food Safety and Nutrition Survey |
Keller and Heckman LLP |
| Sep 8 2025 |
Getting the Green Light: FDA's New Safeguards for GLP-1 Imports |
Katten |
| Sep 8 2025 |
ISO Publishes Standards for Graphene-Related 2D Materials |
Bergeson & Campbell, P.C. |
| Sep 5 2025 |
Ninth Circuit Affirms Dismissal of Securities Fraud Suit: Marketing Slogan Alone Not Actionable Under Section 10(b) and Rule 10b-5 |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 5 2025 |
McDermott+ Check-Up – September 5, 2025 |
McDermott Will & Schulte LLP |
| Sep 5 2025 |
New Foreign Affairs Manual Guidance: Legal Hemp Activities No Longer Grounds for Visa Inadmissibility |
Greenberg Traurig, LLP |
| Sep 5 2025 |
What to Know About the Latest Updates in Ozempic and Wegovy Lawsuits |
Stark & Stark |
| Sep 5 2025 |
Cultivated Meat Companies Sue Texas Over Ban |
Keller and Heckman LLP |
| Sep 5 2025 |
The MAHA Report and the Definition of Ultra-Processed Foods |
Womble Bond Dickinson (US) LLP |
| Sep 4 2025 |
The Price You Pay: California Largely Strikes Down Bill Banning Surveillance Pricing |
Robinson & Cole LLP |
| Sep 4 2025 |
The ABCs of CBD? Kind of… 8th Circuit Affirms Termination of Employee Failing Drug Test for Hemp Pain Oil |
Bradley Arant Boult Cummings LLP |
| Sep 4 2025 |
FDA Releases Report Documenting “Short Weighting” in Some Imported Seafood |
Keller and Heckman LLP |
| Sep 4 2025 |
Bone Broth Company Sued for Allegedly Inflating Protein Amounts |
Keller and Heckman LLP |
| Sep 4 2025 |
NYC Updates Food Standards for City Agencies |
Keller and Heckman LLP |
| Sep 3 2025 |
This Week in 340B: August 26 – September 1, 2025 |
McDermott Will & Schulte LLP |
| Sep 3 2025 |
Healthcare Preview for the Week of: September 2, 2025 |
McDermott Will & Schulte LLP |
| Sep 3 2025 |
Controversy Over “Composition”: Federal Circuit Highlights Drafting Discrepancy |
Womble Bond Dickinson (US) LLP |
| Sep 2 2025 |
The Future of Silicon Valley: Examining the Six Biggest Issues Impacting Innovation and Growth |
Foley & Lardner LLP |
| Sep 2 2025 |
Appellate Court Gives Go-Ahead for 340B Contract Pharmacy Insulin Pricing Suit to Proceed |
Robinson & Cole LLP |
| Sep 2 2025 |
Do Not Bottle the Truth: Major Soft Drinks Company Commits to Correcting its Recycling Claims Under EU Law |
K&L Gates LLP |
| Sep 2 2025 |
EC Publishes Summary Report on Public Consultation for EU Bioeconomy Strategy |
Bergeson & Campbell, P.C. |
